Dosing & Uses
Chronic Obstructive Pulmonary Disease
Pending FDA approval for chronic obstructive pulmonary disease (COPD)
Next:
Pharmacology
Mechanism of Action
Dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 enzymes
Also activates the cystic fibrosis transmembrane conductance regulator (CFTR), which is beneficial in reducing mucous viscosity and improving mucociliary clearance
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
